Dongbang Medical Co., Ltd (KOSDAQ:240550)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Beauty and Other Business	64.29B	-	-
Oriental Medicine Business	40.83B	-	-
Medical Device Manufacturing	-	90.88B	81.41B
Total	105.11B	90.88B	81.41B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	87.15B	85.62B	90.88B	81.41B
Overseas	26.39B	19.49B	-	-
Total	113.54B	105.11B	90.88B	81.41B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error